Erratum: The effect of peer-driven intervention on rates of screening for AIDS clinical trials among African Americans and Hispanics (American Journal of Public Health (2011) 101:6 (1096-1102) DOI: 10.2105/AJPH.2010.196048);The effect of peer-driven intervention on rates of screening for AIDS clinical trials among African Americans and Hispanics

American Journal of Public Health

Volumn 101, Issue 6, 2011, Pages 1096-1102

  Gwadz, Marya Viorst ^a   Leonard, Noelle R ^a   Cleland, Charles M ^a   Riedel, Marion ^b   Banfield, Angela ^a   Mildvan, Donna ^c  

^a NEW YORK UNIVERSITY   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNOLOGY; FEMALE; FOLLOW UP; HEALTH PROMOTION; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PEER GROUP; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

ADOLESCENT; ADULT; AFRICAN AMERICANS; FEMALE; FOLLOW-UP STUDIES; HEALTH PROMOTION; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PEER GROUP; YOUNG ADULT;

EID: 79956352605     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2010.196048e     Document Type: Erratum

References (48)

1. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, by race/ethnicity, 2002-2006. 2008. Available at: http://www.cdc.gov/hiv/topics/surveil lance/resources/ reports/2008supp-vol13no1/pdf/HIVAIDS-SSR-Vol13-No1.pdf. Accessed April 1, 2010.
2. Centers for Disease Control and Prevention. HIV/AIDS among Hispanics, 2004. Available at: http://www.cdc.gov/hiv/pubs/Facts/hispanic.htm. Accessed March 28, 2005.
3. Oramasionwu CU, Hunter JM, Skinner J, et al. Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study. BMC Infect Dis. 2009;9(1):127-139.
4. Centers for Disease Control and Prevention. HIV/AIDS among African-Americans. February 7, 2005. Available at: http://www.cdc.gov/hiv/pubs/ Facts/afam.htm. Accessed March 28, 2005.
5. Centers for Disease Control and Prevention. HIV/AIDS Surveillance report, 2007. 2009. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/2007report/pdf/2007SurveillanceReport.pdf. Accessed June 14, 2010.
6. Rubin MS, Colen CG, Link BG. Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective. Am J Public Health. 2010;100(6):1053-1059.
7. Steele CB, Richmond-Reese V, Lomax S. Racial and ethnic disparities in HIV/AIDS, sexually transmitted diseases, and tuberculosis among women. J Womens Health (Larchmt). 2006;15(2):116-122.
8. Gifford AL, Cunningham WE, Heslin KC, et al. Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002;346:1373-1382. (Pubitemid 34754611)
9. Stone V, Mauch M, Steger K, Janas S, Craven D. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med. 1997;12(3):150-157. (Pubitemid 27180567)
10. National Institute of Allergy and Infectious Diseases. HIV infection in minority populations. 2008. Available at: http://www.niaid.nih.gov/topics/ HIVAIDS/Under standing/Population%20Specific%20Information/Pages/ minorityPopulations.aspx. Accessed February 29, 2010.
11. King WD, Defreitas D, Smith K, et al. Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: A descriptive study. AIDS Patient Care STDS. 2007;21(8):551-563. (Pubitemid 350194957)
12. National Institute of Allergy and Infectious Diseases. Strategic plan for addressing health disparities: Fiscal years 2002-2006. 2002. Available at: http://www.niaid.nih.gov/healthdisparities/NIAID-HD-Plan-Final.pdf. Accessed April 26, 2006.
13. Gwadz MV, Leonard NR, Nakagawa A, et al. Gender differences in attitudes toward AIDS clinical trials among urban HIV-infected individuals from racial and ethnic minority backgrounds. AIDS Care. 2006;18(7):786-794. (Pubitemid 44395525)
14. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3(2): e19.
15. Wynia MK, Gamble VN. Mistrust among minorities and the trustworthiness of medicine. PLoS Med. 2006;3(5): e244; author reply e245. doi: 10.1371/journal.pmed.0030244 (Pubitemid 43807043)
16. Priddy FH, Cheng AC, Salazar LF, Frew PM. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US. Int J STD AIDS. 2006;17(2):99-102.
17. Slomka J, Ratliff EA, McCurdy SA, Timpson S, Williams ML. Decisions to participate in research: Views of underserved minority drug users with or at risk for HIV. AIDS Care. 2008;20(10):1224-1232.
18. Stone VE, Mauch MY, Steger KA. Provider attitudes regarding participation of women and persons of color in AIDS clinical trials. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(3):245-253.
19. Andersen JW, Fass R, van der Horst C. Factors associated with early study discontinuation in AACTG studies, DACS 200. Contemp Clin Trials. 2007;28(5):583-592. (Pubitemid 47212842)
20. Brown-Peterside P, Chiasson MA, Ren L, Koblin BA. Involving women in HIV vaccine efficacy trials: Lessons learned from a vaccine preparedness study in New York City. J Urban Health. 2000;77(3):425-437. (Pubitemid 30658855)
21. Schuster MA, Kanouse DE, Morton SC, et al. HIV- infected parents and their children in the United States. Am J Public Health. 2000;90(7):1074-1081. (Pubitemid 30445361)
22. Gwadz MV, Cylar K, Leonard NR, et al. An exploratory behavioral intervention trial to improve rates of screening for AIDS clinical trials among racial/ethnic minority and female persons living with HIV/AIDS. AIDS Behav. 2010;14(3):639-648.
23. Freedberg KA, Sullivan L, Georgakis A, Savetsky J, Stone V, Samet JH. Improving participation in HIV clinical trials: Impact of a brief intervention. HIV Clin Trials. 2001;2(3):205-212. (Pubitemid 32600390)
24. Heckathorn DD. Collective sanctions and compliance norms: A formal theory of group-mediated social control. Am Sociol Rev. 1990;55:366-384.
25. Heckathorn DD. Collective action and group heterogeneity: Voluntary provision versus selective incentives. Am Sociol Rev. 1993;58:329-350.
26. Broadhead RS, Heckathorn DD, Weakliem DL, et al. Harnessing peer education networks as an instrument for AIDS prevention. Public Health Rep. 1998;113(Suppl 1):42-57. (Pubitemid 29330145)
27. Heckathorn DD, Broadhead RS, Anthony DL, Weakliem DL. AIDS and social networks: HIV prevention through network mobilization. Sociol Focus. 1999;32:159-179.
28. Broadhead RS, Heckathorn DD, Altice FL, et al. Increasing drug users' adherence to HIV treatment: Results of a peer-driven intervention feasibility study. Soc Sci Med. 2002;55(2):235-246. (Pubitemid 34621441)
29. Cottler LB, Compton WM, Ben-Abdallah A, Horne M, Claverie D. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend. 1996;41(3):209-217. (Pubitemid 26252463)
30. Flay B, Petraitis J. The theory of triadic influence. In: Albrecht G, ed. Advances in Medical Sociology. Vol IV. Greenwich, CT: JAI Press; 1994:19-44.
31. Heckathorn DD. Respondent-driven sampling: A new approach to the study of hidden population. Soc Probl. 1997;44(2):174-199.
32. Hettema J, Steele J, Miller WR. Motivational interviewing. Annu Rev Clin Psychol. 2005;1:91-111. (Pubitemid 43843947)
33. Miller W, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed. New York, NY: Guilford; 2002.
34. Ewart CK. Social action theory for a public health psychology. Am Psychol. 1991;46(9):931-946.
35. Bandura A. Social Foundations of Thought and Action. Englewood Cliffs, NJ: Prentice Hall; 1986.
36. Abdul-Quader AS, Heckathorn DD, McKnight C, et al. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: Findings from a pilot study. J Urban Health. 2006;83(3):459-476. (Pubitemid 44341557)
37. Semaan S, Lauby J, Liebman J. Street and network sampling in evaluation studies of HIV risk-reduction interventions. AIDS Rev. 2002;4:213-223. (Pubitemid 36104232)
38. Wang J, Carlson R, Falck R, Siegal H, Rahman A, Li L. Respondent-driven sampling to recruit MDMA users: A methodological assessment. Drug Alcohol Depend. 2005;78(2):147-157. (Pubitemid 40544602)
39. Questionnaire Development System. Bethesda, MD: Nova Research Company; 2001.
40. Des Jarlais D, Paone D, Milliken J, et al. Audiocomputer interviewing to measure HIV risk behaviour among injecting drug users: A quasi-randomised trial. Lancet. 1999;353(9165):1657-1661. (Pubitemid 29224522)
41. HIV Cost and Services Utilization Study. Baseline Questionnaire. Fact Sheet. Rockville, MD: Agency for Health Care Policy and Research; 1995.
42. National Institute on Drug Abuse. Risk Behavior Assessment. Rockville, MD: National Institute on Drug Abuse; 1991.
43. Kalichman SC, Rompa D, Cage M, et al. Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people. Am J Prev Med. 2001;21(2):84-92. (Pubitemid 32660421)
44. McCulloch CE, Searle SR. Generalized, Linear, and Mixed Models. New York, NY: Wiley; 2001.
45. Bates D, Maechler M. lme4: Linear mixed-effects models using S4 classes. R package version 0.999375.32. 2009. Available at: http://CRAN. R-project.org/package=lme4. Accessed January 11, 2010.
46. R Development Core Team. R: A language and environment for statistical computing. 2009. Available at: http://www.r-project.org. Accessed February 12, 2009.
47. Gandhi M, Ameli N, Bacchetti P, et al. Eligibility criteria for HIV clinical trials and generalizability of results: The gap between published reports and study protocols. AIDS. 2005;19(16):1885-1896. (Pubitemid 41546608)
48. Marshak A, Costantini G, Middleton S, et al. Screening for AIDS clinical trials in the project ACT cohort of racial/ethnic minorities and women in New York City: substantial interest but low eligibility. Poster presented at: 4th International AIDS Society Conference; July 2007; Sydney, Australia.